Madrigal Pharmaceuticals Inc (MDGL) — Financial Flexibility Index
Madrigal Pharmaceuticals Inc (MDGL) has a Financial Flexibility Index of -0.20x as of December 2025. Free cash flow of $-133.07 Million (operating CF $-133.46 Million minus capex $390.00K) represents 0% of total liabilities ($656.90 Million). Also explore how fast is Madrigal Pharmaceuticals Inc growing its equity to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Madrigal Pharmaceuticals Inc Financial Flexibility Index (2003–2025)
Historical Financial Flexibility Index trend for Madrigal Pharmaceuticals Inc across 23 annual periods. Check asset allocation strategy of Madrigal Pharmaceuticals Inc to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Madrigal Pharmaceuticals Inc (2003–2025)
Year-by-year free cash flow to debt coverage for Madrigal Pharmaceuticals Inc. For the full company profile including market capitalisation, see market value of Madrigal Pharmaceuticals Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.29x | $-189.09 Million | $-189.55 Million | $656.90 Million | ▲ +81.8% |
| 2024 | -1.58x | $-454.11 Million | $-455.57 Million | $287.86 Million | ▼ -15.0% |
| 2023 | -1.37x | $-322.75 Million | $-324.23 Million | $235.21 Million | ▼ -0.9% |
| 2022 | -1.36x | $-224.64 Million | $-224.86 Million | $165.18 Million | ▲ +42.8% |
| 2021 | -2.38x | $-183.71 Million | $-183.92 Million | $77.22 Million | ▲ +28.9% |
| 2020 | -3.34x | $-157.23 Million | $-157.56 Million | $47.02 Million | ▼ -105.6% |
| 2019 | -1.63x | $-41.45 Million | $-41.62 Million | $25.49 Million | ▲ +46.1% |
| 2018 | -3.02x | $-25.48 Million | $-25.51 Million | $8.44 Million | ▼ -36.7% |
| 2017 | -2.21x | $-22.19 Million | $-22.32 Million | $10.05 Million | ▲ +39.8% |
| 2016 | -3.67x | $-17.60 Million | $-17.61 Million | $4.80 Million | ▲ +8.6% |
| 2015 | -4.01x | $-71.39 Million | $-71.44 Million | $17.79 Million | ▼ -81.0% |
| 2014 | -2.22x | $-78.78 Million | $-78.92 Million | $35.54 Million | ▼ -33.4% |
| 2013 | -1.66x | $-76.64 Million | $-77.41 Million | $46.11 Million | ▲ +13.4% |
| 2012 | -1.92x | $-53.63 Million | $-54.13 Million | $27.95 Million | ▼ -13.4% |
| 2011 | -1.69x | $-46.61 Million | $-47.30 Million | $27.55 Million | ▼ -36.0% |
| 2010 | -1.24x | $-38.06 Million | $-38.20 Million | $30.59 Million | ▼ -13.3% |
| 2009 | -1.10x | $-26.36 Million | $-26.81 Million | $24.00 Million | ▼ -379.3% |
| 2008 | -0.23x | $-35.76 Million | $-37.94 Million | $156.04 Million | ▼ -175.7% |
| 2007 | 0.30x | $29.57 Million | $27.22 Million | $97.75 Million | ▲ +133.3% |
| 2006 | -0.91x | $-51.41 Million | $-52.98 Million | $56.54 Million | ▲ +70.1% |
| 2005 | -3.04x | $-57.00 Million | $-61.88 Million | $18.73 Million | ▼ -32.9% |
| 2004 | -2.29x | $-32.20 Million | $-33.80 Million | $14.06 Million | ▲ +65.0% |
| 2003 | -6.53x | $-22.84 Million | $-23.61 Million | $3.50 Million | — |